{
  "trial_id": "NCT02357810",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, sex, race, ECOG performance status, histological subtype of sarcoma, prior chemotherapy regimens, presence of brain metastasis, absolute neutrophil count (ANC), hemoglobin level, platelet count, prothrombin time (PT) or international normalized ratio (INR), activated partial thromboplastin time (aPTT), total bilirubin, alanine aminotransferase (ALT) level, aspartate aminotransferase (AST) level, serum creatinine, urine protein to creatinine ratio (UPC), pregnancy status for females of child-bearing potential (FOCBP), ability to swallow and retain oral tablets.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Histology",
          "histological subtype of sarcoma"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Ethnicity (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "ECOG performance status",
        "prior chemotherapy regimens",
        "presence of brain metastasis",
        "absolute neutrophil count (ANC)",
        "hemoglobin level",
        "platelet count",
        "prothrombin time (PT) or international normalized ratio (INR)",
        "activated partial thromboplastin time (aPTT)",
        "total bilirubin",
        "alanine aminotransferase (ALT) level",
        "aspartate aminotransferase (AST) level",
        "serum creatinine",
        "urine protein to creatinine ratio (UPC)",
        "pregnancy status for females of child-bearing potential (FOCBP)",
        "ability to swallow and retain oral tablets."
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, ECOG Performance Status, Histologic Subtype, Number of Prior Chemotherapy Regimens, Presence of Brain Metastasis, Absolute Neutrophil Count (ANC), Hemoglobin, Platelets, Prothrombin Time (PT) or International Normalized Ratio (INR), Activated Partial Thromboplastin Time (aPTT), Total Bilirubin, Alanine Aminotransferase (ALT), Aspartate Aminotransferase (AST), Serum Creatinine, Urine Protein to Creatinine Ratio (UPC), ",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Histology",
          "Histologic Subtype"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Ethnicity (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "ECOG Performance Status",
        "Number of Prior Chemotherapy Regimens",
        "Presence of Brain Metastasis",
        "Absolute Neutrophil Count (ANC)",
        "Hemoglobin",
        "Platelets",
        "Prothrombin Time (PT) or International Normalized Ratio (INR)",
        "Activated Partial Thromboplastin Time (aPTT)",
        "Total Bilirubin",
        "Alanine Aminotransferase (ALT)",
        "Aspartate Aminotransferase (AST)",
        "Serum Creatinine",
        "Urine Protein to Creatinine Ratio (UPC)"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, ECOG Performance Status, Histological Diagnosis, Number of Prior Chemotherapy Regimens, Presence of Brain Metastases, Absolute Neutrophil Count, Hemoglobin, Platelet Count, Prothrombin Time, International Normalized Ratio, Activated Partial Thromboplastin Time, Total Bilirubin, Alanine Aminotransferase, Aspartate Aminotransferase, Serum Creatinine, Calculated Creatinine Clearance, Urine Protein to Creatinine Ratio.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Histology",
          "Histological Diagnosis"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Race (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "ECOG Performance Status",
        "Number of Prior Chemotherapy Regimens",
        "Presence of Brain Metastases",
        "Absolute Neutrophil Count",
        "Hemoglobin",
        "Platelet Count",
        "Prothrombin Time",
        "International Normalized Ratio",
        "Activated Partial Thromboplastin Time",
        "Total Bilirubin",
        "Alanine Aminotransferase",
        "Aspartate Aminotransferase",
        "Serum Creatinine",
        "Calculated Creatinine Clearance",
        "Urine Protein to Creatinine Ratio"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, Eastern Cooperative Oncology Group (ECOG) performance status, histological diagnosis, number of prior chemotherapy regimens, presence of brain metastasis, absolute neutrophil count (ANC), hemoglobin, platelet count, prothrombin time (PT) or international normalized ratio (INR), activated partial thromboplastin time (aPTT), total bilirubin, alanine amino transferase (ALT), aspartate aminotransferase (AST), serum creatinine, urine protein to creatinine ratio (UPC), corrected QT interval (QTc).",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Histology",
          "histological diagnosis"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Ethnicity (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "Eastern Cooperative Oncology Group (ECOG) performance status",
        "number of prior chemotherapy regimens",
        "presence of brain metastasis",
        "absolute neutrophil count (ANC)",
        "hemoglobin",
        "platelet count",
        "prothrombin time (PT) or international normalized ratio (INR)",
        "activated partial thromboplastin time (aPTT)",
        "total bilirubin",
        "alanine amino transferase (ALT)",
        "aspartate aminotransferase (AST)",
        "serum creatinine",
        "urine protein to creatinine ratio (UPC)",
        "corrected QT interval (QTc)"
      ]
    }
  }
}